July 8, 2026, 12:53 PM EDT. Oklo (OKLO) secured a key okay from the U.S. Department of Energy for its Groves Isotope Test Reactor, a step forward on its nuclear project. The news hasn't helped shares, which have dropped 17.54% in the past month and more than 38% this year. Oklo posted a $128.9 million net loss with zero revenue. Some analysts put fair value at $80.55 a share, compared to Friday's $47.90 close. The company is betting on long-term power contracts for its modular reactors, including a 12 GW deal out to 2044 with Switch. With no operating reactors yet, investors are watching for revenue to keep up with expectations while considering the risks.
